“Remodeling” Mesothelioma Cells May Improve Responsiveness to Immunotherapy
Italian researchers are experimenting with the idea of remodeling mesothelioma cells from the inside out to improve their responsiveness to immunotherapy. Malignant mesothelioma is highly resistant to standard cancer treatments. Immunotherapy is widely considered to be one of the most hopeful new approaches to this cancer. But this approach works better for some people than it does for others. The difference may lie in the genes. Scientists at University Hospital of Siena believe that manipulating the gene expression of mesothelioma cells could be the key to bolstering responsiveness to immunotherapy. Mesothelioma, Genetics, and Responsiveness to Immunotherapy Immunotherapy is a method of treating disease by using the body’s natural immune response. This can mean trying to attract more immune cells to … Continue reading “Remodeling” Mesothelioma Cells May Improve Responsiveness to Immunotherapy
Could This Protein Play a Role in Survival of Pleural Mesothelioma?
Research funded by the National Cancer Institute has identified a protein that might play a key role in survival of pleural mesothelioma. The protein is called UHRF1. It is encoded by a gene of the same name. Researchers believe it may be a driver of growth and spread in malignant mesothelioma. The research will have to be confirmed on a larger scale. But if it turns out to be true, it could give doctors a new way to extend survival of pleural mesothelioma. Finding Drivers of Mesothelioma Growth Pleural mesothelioma is a membrane (mesothelium) cancer caused by asbestos exposure. Although some people do survive mesothelioma, it is rare. Average survival of pleural mesothelioma is right around 18 months. It can … Continue reading Could This Protein Play a Role in Survival of Pleural Mesothelioma?